XML 60 R15.htm IDEA: XBRL DOCUMENT v3.20.1
Share-Based Compensation
12 Months Ended
Dec. 31, 2019
Share-based Payment Arrangement [Abstract]  
Share-Based Compensation

NOTE 9: SHARE-BASED COMPENSATION

 

Stock Options

 

During the years ended December 31, 2019 and 2018, the Company granted options for the purchase of the Company’s common stock to certain employees, consultants and advisors as consideration for services rendered. The terms of the stock option grants are determined by the Company’s Board of Directors. The Company’s stock options generally vest upon the one-year anniversary date of the grant and have a maximum term of ten years.

 

The following summarizes the stock option activity for the years ended December 31, 2019 and 2018:

 

    Options Outstanding     Weighted-Average
Exercise Price
 
Balance as of December 31, 2017     -       -  
Grants of stock options     307,021       3.71  
Awards Canceled     (140,636 )     3.09  
Balance as of December 31, 2018     166,385     $       3.45  
Grants of stock options     295,810       1.09  
Cancelled stock options     (84,968 )     3.82  
Balance as of December 31, 2019     377,227     $ 1.86  

 

The weighted average grant date fair value of stock options granted during the year ended December 31, 2019 was $0.72. The total fair value of stock options that granted during the year ended December 31, 2019 was approximately $211,838. The fair value of each stock option is estimated on the date of grant using the Black-Scholes-Merton option pricing model with the following weighted average assumptions for stock options granted during the year ended December 31, 2019:

 

Expected term (years)     2.8  
Expected stock price volatility     153.58 %
Weighted-average risk-free interest rate     1.13 %
Expected dividend   $ 0.00  

 

Volatility is a measure of the amount by which a financial variable such as share price has fluctuated (historical volatility) or is expected to fluctuate (expected volatility) during a period. The Company estimates expected volatility giving primary consideration to the historical volatility of its common stock. The risk-free interest rate is based on the published yield available on U.S. Treasury issues with an equivalent term remaining equal to the expected life of the stock option. The expected lives of the stock options represent the estimated period of time until exercise or forfeiture and are based on the simplified method of using the mid-point between the vesting term and the original contractual term.

 

The following summarizes certain information about stock options vested and expected to vest as of December 31, 2019:

 

    Number of     Weighted-Average Remaining Contractual Life     Weighted- Average
Exercise
 
    Options     (In Years)     Price  
Outstanding     377,277       6.64     $ 1.86  
Exercisable     112,100       5.81       3.95  
Expected to vest     265,127       6.99     $ 0.98  

 

As of December 31, 2019 and 2018, there was approximately $18,229 and $142,000, respectively, of total unrecognized compensation cost related to non-vested share-based compensation arrangements which is expected to be recognized within the next year.

 

Restricted Stock Awards

 

During the years ended December 31, 2019 and 2018, the Company issued restricted stock awards for shares of common stock which have been reserved for the holders of the awards. Restricted stock awards were issued to certain consultants and advisors as consideration for services rendered. The terms of the restricted stock units are determined by the Company’s Board of Directors. The Company’s restricted stock shares generally vest over a period of one year and have a maximum term of ten years.

 

The following summarizes the restricted stock activity for the years ended December 31, 2019 and 2018:

 

          Weighted-Average  
    Shares     Fair Value  
Balance as of December 31, 2017     -       -  
Shares of restricted stock granted     235,576       3.13  
Exercised     -       -  
Cancelled     (109,144 )             2.47  
Balance as of December 31, 2018     126,432     $ 3.70  
Shares of restricted stock granted     900,203       0.78  
Exercised     (261,135 )     1.67  
Cancelled     (241,163 )     0.95  
Balance as of December 31, 2019     524,337       0.79  

 

    December 31,  
Number of Restricted Stock Awards   2019     2018  
Vested     57,243       -  
Non-vested     467,094       126,432  

 

As of December 31, 2019 and 2018, there was approximately $147,743 and $291,000, respectively, of total unrecognized compensation cost related to non-vested share-based compensation, which is expected to be recognized over the next year.